Skip to main content
Log in

Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV

  • Empirical Research
  • Published:
Annals of Behavioral Medicine

Abstract

Investigations in both healthy and clinical populations support the effectiveness of cognitive-behavioral interventions for immune enhancement and symptom reduction. However, there is a paucity of research examining these interventions in human immunodeficiency virus (HIV) positive populations, and existing studies lack precision in design. In this study, HIV seropositive subjects, blocked by illness stage, were randomized to a guided imagery (N=23) or progressive muscle relaxation (PMR) (N=22) treatment, or a control group (N = 24). The six-week treatments were delivered via audiotape following brief face-to-face instruction, and effects on fatigue, depression, and three measures of cellular immunity were examined. Pre and posttreatment measures included the Center for Epidemiologic Studies Depression Scale (CES-D), Sleep and Rest subscale of the Sickness Impact Profile (SIP), CD4+ and CD16+ lymphocyte numbers, and CD4+:CD8 + T lymphocyte ratio. Data were analyzed using a hierarchical multiple regression model, holding pretreatment effects constant while assessing the contribution of each treatment to the dependent variables. The guided imagery group had a significant decrease in depression and fatigue, while the PMR group demonstrated an increased CD4+ T lymphocyte count and a reduction in depression. Findings supported the effectiveness of both interventions for symptom alleviation, and of PMR for immune enhancement in persons with HIV, and suggest a differential effect for the two treatments in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Centers for Disease Control: Pneumocystis pneumonia-Los Angeles.Morbidity and Mortality Weekly Report. 1981,30:250–252.

    Google Scholar 

  2. Centers for Disease Control: The HIV/AIDS epidemic: The first 10 years.Morbidity and Mortality Weekly Report. 1991,40:357–369.

    Google Scholar 

  3. Collier AC, Bozzette S, Coombs RW, et al: A pilot study of low-dose zidovudine in human immunodeficiency virus infection.New England Journal of Medicine. 1990,525:1015–1021.

    Google Scholar 

  4. Kaslow RA, Phair JP, Freidman HB, et al: Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency.Annals of Internal Medicine. 1987,107:474–480.

    PubMed  CAS  Google Scholar 

  5. Graham NMH, Zeger SL, Park LP, et al: The effects of early treatment of human immunodeficiency virus infection.New England Journal of Medicine. 1992,526:1037–1042.

    Google Scholar 

  6. Clement M, Hollander H: Natural history and management of the seropositive patient. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 87–96.

    Google Scholar 

  7. Fox R, Eldred LJ, Fuchs EJ, et al: Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men.AIDS. 1987,1:35–38.

    PubMed  CAS  Google Scholar 

  8. Flaskerud JH, Ungvarski PJ:HIV/AIDS: A Guide to Nursing Care. Philadelphia, PA: W. B. Saunders, 1992.

    Google Scholar 

  9. National Center for Nursing Research:HIV Infection: Prevention and Care. Bethesda, MD: U.S. Department of Health and Human Services, 1990.

    Google Scholar 

  10. National Institute of Allergy and Infectious Diseases:HIV/AIDS Research Agenda: Executive Summary. Washington, DC: National Institutes of Health, 1993.

    Google Scholar 

  11. Cunningham AJ: Mind, body, and immune response. In Ader R (ed),Psychoneuroimmunology. San Diego, CA: Academic Press, 1981, 609–617.

    Google Scholar 

  12. Pert C, Ruff MR, Weber RJ, et al: Neuropeptides and their receptors: A psychosomatic network.The Journal of Immunology. 1985,135:820s-826s.

    PubMed  CAS  Google Scholar 

  13. Wybran J, Schandene L, Van Vooren JP, et al: Immunologic properties of methionine-enkephalin, and therapeutic implications in AIDS, ARC, and cancer.Annals of the New York Academy of Sciences. 1987,496:108–114.

    Article  PubMed  CAS  Google Scholar 

  14. Plotnikoff NP, Miller GC, Nimeh N, et al: Enkephalins and T-cell enhancement in normal volunteers and cancer patients.Annals of the New York Academy of Sciences. 1987,496:608–619.

    Article  PubMed  CAS  Google Scholar 

  15. Teshima H, Sogawa H, Mizobe K, et al: Application of psychoim-munotherapy in patients with alopecia universalis.Psychotherapy and Psychosomatics. 1991,56:235–241.

    PubMed  CAS  Google Scholar 

  16. Levy JA: Viral and immunologic factors in HIV infection. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 18–32.

    Google Scholar 

  17. Roitt I, Brostoff J, Male D:Immunology. St. Louis, MO: Mosby, 1994.

    Google Scholar 

  18. Stites DP, Terr AI, Parslow TG:Basic and Clinical Immunology. Norwalk, CT: Appleton Lange, 1994.

    Google Scholar 

  19. Saag MS: AIDS testing: Now and in the future. In Sande MA, Volberding PA (eds),The Medical Management of AIDS. Philadelphia, PA: Saunders, 1992, 33–53.

    Google Scholar 

  20. Gerstoff J, Dickmeiss E, Mathieson L: Cytotoxic capabilities of lymphocytes from patients with the acquired immunodeficiency syndrome.Scandinavian Journal of Immunology. 1985,22:463–470.

    Article  Google Scholar 

  21. (21)Ticchioni M, Sapir J, Pugliese P, et al: Natural killer cells at different clinical stages of human immunodeficiency virus infection: A one-year prospective study of 163 patients.The Ninth International Conference on AIDS, (Abstract No. PO-A24-0552). Berlin, Germany: 1993.

  22. Cai Q, Huang X, Rappocciolo G, et al: Natural killer cell responses in homosexual men with early HIV infection.Journal of Acquired Immune Deficiency Syndromes. 1990,5:669–676.

    Google Scholar 

  23. Longo MB, Spross JA, Locke AM: Identifying major concerns of persons with AIDS.Clinical Nurse Specialist. 1990,4:21–26.

    Article  PubMed  CAS  Google Scholar 

  24. Nyamathi AM, Hedderman M: Community issues. In Flaskerud JH (ed),AIDS/HIV Infection. Philadelphia, PA: Saunders, 1989, 198–214.

    Google Scholar 

  25. Perry SW, Tross S: Psychiatric problems of AIDS in-patients at the New York Hospital: A preliminary report.Public Health Reports. 1984,99:200–205.

    PubMed  CAS  Google Scholar 

  26. Rodin G, Craven J, Littlefleld C:Depression in the Medically Ill. New York: Brunner/Mazel, 1991.

    Google Scholar 

  27. Tross S, Hirsch DA: Psychological distress and neuropsychological complications of HIV infection and AIDS.American Psychologist. 1988,43:929–934.

    Article  PubMed  CAS  Google Scholar 

  28. (28)Williams C, Lubeck DP: HIV related fatigue.The Ninth International Conference on AIDS, (Abstract No. PO-B01-0885). Berlin, Germany: 1993.

  29. Darko DF, McCutchan JA, Kripke DF, et al: Fatigue, sleep disturbance, disability, and indices of progression of HIV infection.American Journal of Psychiatry. 1992,149:514–520.

    PubMed  CAS  Google Scholar 

  30. (30)Doob PR, MacFadden DK: The impact of peptide T on HIV-related fatigue and health-related quality-of-life.The Eighth International Conference on AIDS, (Abstract No. PuB 7149). Amsterdam: 1992.

  31. (31)Burack JH, Stall RD, Barrett DC, et al: Depression predicts accelerated CD4 decline among gay men in San Francisco.The Eighth International Conference on AIDS, (Abstract No. WeC 1031). Amsterdam: 1992.

  32. Lyketsos CG, Hoover DR, Guccione M, et al: Depressive symptoms as predictors of medical outcomes in HIV.Journal of the American Medical Association. 1993,270:2563–2567.

    Article  PubMed  CAS  Google Scholar 

  33. Herbert TB, Cohen S: Depression and immunity: A meta-analytic review.Psychological Bulletin. 1993,113:472–486.

    Article  PubMed  CAS  Google Scholar 

  34. Kemeny ME, Weiner H, Taylor SE, et al: Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men.Health Psychology. 1994,13:14–24.

    Article  PubMed  CAS  Google Scholar 

  35. Solomon GF, Kemeny MF, Temoshok L: Psychoneuroimmuno-logic aspects of human immunodeficiency virus infection. In Ader R, Felten DL, Cohen N (eds),Psychoneuroimmunology. New York: Academic Press, 1991, 1081–1113.

    Google Scholar 

  36. (36)Temoshok L, Sweet DM, Moulton JM, et al: A longitudinal study of distress and coping in men with AIDS and AIDS related complex.The Third International Conference on AIDS, (Abstract No. WP. 201). Washington, DC: 1987.

  37. Ostrow DG, Monjan A, Joseph J, et al: HIV-related symptoms and psychological functioning in a cohort of homosexual men.American Journal of Psychiatry. 1989,146:737–742.

    PubMed  CAS  Google Scholar 

  38. Rabkin JG, Williams JB, Remien RH, et al: Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men.Archives of General Psychiatry. 1991,48:111–119.

    PubMed  CAS  Google Scholar 

  39. Kelly JA, Murphy DA: Psychological interventions with AIDS and HIV: Prevention and treatment.Journal of Consulting and Clinical Psychology. 1992,60:576–585.

    Article  PubMed  CAS  Google Scholar 

  40. Miller D, Riccio M: Non-organic and psychosocial syndromes associated with HIV-1 infection and disease.AIDS. 1990,4:381–388.

    Article  PubMed  CAS  Google Scholar 

  41. Black S, Humphrey JH, Niven JS: Inhibition of immediate-type hypersensitivity response by direct suggestion under hypnosis.British Medical Journal. 1963,1:925–929.

    Article  PubMed  CAS  Google Scholar 

  42. Zacharaiae R, Bjerring P, Arendt-Nielsen L: Modulation of Type I immediate and Type IV delayed immunoreactivity using direct suggestion and guided imagery during hypnosis.Allergy. 1989,44: 537–542.

    Article  Google Scholar 

  43. Rider MS, Achterberg J: Effect of music-assisted imagery on neutrophils and lymphocytes.Biofeedback and Self-Regulation. 1989,14:247–257.

    Article  PubMed  CAS  Google Scholar 

  44. Zachariae R, Kristensen JS, Hokland P, et al: Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects.Psychotherapy and Psychosomatics. 1990,54:32–39.

    Article  PubMed  CAS  Google Scholar 

  45. Hall HR, Minnes L, Tosi M, et al: Voluntary modulation of neutrophil adhesiveness using a cyberphysiologic strategy.International Journal of Neuroscience. 1992,63:287–297.

    Article  PubMed  CAS  Google Scholar 

  46. Jasnoski ML, Kugler J: Relaxation, imagery, and neuroimmuno-modulation.Annals of the New York Academy of Sciences. 1987,496:722–730.

    Article  PubMed  CAS  Google Scholar 

  47. Olness K, Culbert T, Uden D: Self-regulation of salivary immunoglobulin A by children.Pediatrics. 1989,83:66–71.

    PubMed  CAS  Google Scholar 

  48. Antoni MH, Baggett L, August S, et al: Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity.Journal of Clinical and Consulting Psychology. 1991,59:906–915.

    Article  CAS  Google Scholar 

  49. (49)Coates SJ, McKusick L: The efficacy of stress management in reducing high risk behavior and improving immune function in HIV antibody positive men.The Third International Conference on AIDS, (Abstract No. WP. 232). Washington, DC: 1987.

  50. Auerbach JE, Oleson TD, Solomon GF: Biofeedback, guided imagery, and hypnosis as an adjunctive treatment for AIDS and AIDS-related complex.Proceedings of the Third National Conference on the Psychology of Health, Immunity, and Disease. Storrs, CT: The National Institute for the Clinical Application of Behavioral Medicine, 1992, 50.

    Google Scholar 

  51. Coates TJ, McKusick L, Kuno R, et al: Stress reduction training changed number of sexual partners but not immune function in men with HIV.American Journal of Public Health. 1989,79:885–886.

    PubMed  CAS  Google Scholar 

  52. (52)Karasic D, Targ E, Diefenbach P, et al: Structured group therapy and fluoxetine as treatment for mood disorder in HIV-seropositive individuals.The Eighth International Conference on AIDS, (Abstract No. PuB 7272). Amsterdam: 1992.

  53. Bohachick P: Progressive relaxation training in cardiac rehabilitation: Effect on psychologic variables.Nursing Research. 1984,33:283–287.

    Article  PubMed  CAS  Google Scholar 

  54. Jarvinien PJ, Gold SR: Imagery as an aid in reducing depression.Journal of Clinical Psychology. 1981,57:523–529.

    Article  Google Scholar 

  55. Leja AM: Using guided imagery to combat postsurgical depression.Journal of Gerontological Nursing. 1989,15:6–11.

    Google Scholar 

  56. Fawzy FI, Namir S, Wolcott DL: Structured group intervention model for AIDS patients.Psychiatric Medicine. 1989,7:35–45.

    PubMed  CAS  Google Scholar 

  57. (57)Mulder CL, Emmelkamp PM, Antoni MH, et al: Immunological and psychological effects of a cognitive behavioral vs. an experiential group therapy program for asymptomatic HIV seropositive homosexual men.The Eighth International Conference on AIDS, (Abstract No. PoB 3809). Amsterdam: 1992.

  58. Perry SW, Fishman B, Jacobsberg L, Young J, Frances A: Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing.Archives of General Psychiatry. 1991,48:143–147.

    PubMed  CAS  Google Scholar 

  59. Centers for Disease Control: Human immunodeficiency virus (HIV) infection codes and new codes for Kaposi’s sarcoma.Mortality and Morbidity Weekly Report. 1991,40(RR-9):1–9.

    Google Scholar 

  60. Kiecolt-Glaser JK: Methodological issues in behavioral immunology research with humans.Brain, Behavior and Immunity. 1987,2:67–78.

    Article  Google Scholar 

  61. Taylor JMG, Fahey JL, Detels R, et al: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use.Journal of Acquired Immune Deficiency Syndromes. 1989,2:114–124.

    PubMed  CAS  Google Scholar 

  62. Bergner M, Bobbin RA, Carter WB, et al: The Sickness Impact Profile.Medical Care. 1981,79:787–805.

    Article  Google Scholar 

  63. Barofsky I, Legro MW: Definition and measurement of fatigue.Review of Infectious Diseases. 1991,75(Suppl. 1):S94-S97.

    Google Scholar 

  64. Radloff LS: The CES-D scale.Applied Psychological Measurement. 1977,1:385–401.

    Article  Google Scholar 

  65. Lipsey MW: Design Sensitivity.Newbury Park, CA: Sage, 1990.

    Google Scholar 

  66. Cohen J:Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.

    Google Scholar 

  67. Kiecolt-Glaser JK, Glaser R: Stress and immune function. In Ader R, Felten DL, Cohen N (eds),Psychoneuroimmunology. New York: Academic Press, 1991, 849–867.

    Google Scholar 

  68. (68)Eller LS: Effects of cognitive-behavioral interventions: Health-related quality-of-life and cellular immunity in persons with HIV.Psychoneuroimmunology Research Society, Research Perspectives in Psychoneuroimmunology, (Abstract No. A43). Key Biscayne, FL: November 16–20, 1994.

Download references

Author information

Authors and Affiliations

Authors

Additional information

Preparation of this manuscript was supported in part by a grant from University Hospitals of Cleveland, Cleveland, OH, and a postdoctoral fellowship to the author from the National Institute of Nursing Research (No. T32 NR07052, Janice M. Zeller, R.N., Ph.D., Project Director).

About this article

Cite this article

Lucille Sanzero Eller, R.N. Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. ann. behav. med. 17, 339–348 (1995). https://doi.org/10.1007/BF02888599

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02888599

Keywords

Navigation